Stem Cell Therapy Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2016 to 2021 and Forecast 2022 to 2028

$ PRICE - $ 3,000.00$ 8,900.00

Global Stem Cell Therapy Market: By Treatment (Allogeneic, Autologous), By Cell Type (Adult Stem Cells, Induced Pluripotent Stem Cells, Human Embryonic Stem Cells, Others), By Technology (Cell Production, Cell Acquisition, Cryopreservation), By End-User (Hospitals, Ambulatory Surgical Centers, Research Centers) and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Categories: ,

Report

Description

Stem Cell Therapy Market size was valued at USD 16.5 billion in 2021 and is expected to reach USD 32.2 billion by 2028, at a CAGR of 10% during the forecast period 2022 to 2028. Stem cell therapy involves use of stem cells to treat various diseases or disorders. Stem cells are fundamental for every tissue and organ in the body.  Stem cells are indistinguishable biological cells that are able to differentiate into specialised cells (liver cells, cardiac cells etc.) and can renew itself (through mitosis) to produce more stem cells. Stem cells have the ability to replicate, repair, and replace other damaged tissues in the human body. In addition, stem cell based therapies are also used to treat several chronic diseases such as blood disorders, cancer and others. Stakeholders in stem cell therapy such as academic institutions and research firms are collaborating in development of stem cell therapy and industry collaborations also projecting enormous growth of stem cell therapy market. For instance, in November 2015, Cellular Dynamics International, Inc. (FUJIFILM) collaborated with Roche to supply iCell (CDI’s induced pluripotent stem cell derived) products that enables in identification of novel drug candidates at the early stages of drug discovery. Similarly, in May 2017, Magenta Therapeutics, entered into strategic partnership with Be The Match BioTherapies, to improve and expand the use of curative stem cell transplantation.

Stem Cell Therapy Market

MARKET SUMMARY
-
10%
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– 10%
  • Largest Market– North America
  • Fastest Growing Market– Asia Pacific

Stem Cell Therapy Market

  • The report on global stem cell therapy market gives historical, current and future market sizes (US$ Mn) on the basis of treatment mode, cell types, application, technology, end-user and region.
  • Stem Cell Therapy Market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
Market Key Players
  • Cytori Therapeutics Inc
  • Fibrocell Science
  • Cellartis AB (Cellectis)
  • BioTime, Inc
  • GE Healthcare
  • Thermo Fisher Scientific
  • STEMCELL Technologies
Growth

Stem Cell Therapy Market

Growing awareness about the potency of stem cells in disease management, development of advanced gene based analysis techniques and increase in public, private investments in stem cell research are acting as growth drivers for stem cell therapy market. In addition, identification of new stem cell lines and development of infrastructure for stem cell banking & processing are propelling the growth of the global stem cell therapy market. However, ethical issues involved in stem cells research such as destruction of human embryos, religious beliefs are considered as road blocks for adaptation of stem cell therapy by patients. However, stringent regulations to conduct trials on humans, high-cost of research and storage of stem cells are some restraining factors for stem cell therapy market.


North-America Got Significant Share

Stem Cell Therapy Market

Geographically stem cell therapy market has been segmented into following regions viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Among the regions, North America dominates global stem cell therapy market due to factors such as increasing prevalence of chronic diseases, growing awareness, and rising investment in research and development activities. In Asia Pacific region, due to the favourable government policies, development healthcare infrastructure, industry collaborations in research and developments expected to boost stem cell therapy market. For instance, in April 2017, Plasticell, a developer of stem cell technologies and cell-based therapies, has announced that it has signed agreements with the Agency for Science, Technology and Research (A*STAR), Singapore, and the Nanyang Technological University (NTU), Singapore, to progress its therapeutic stem cell pipeline.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Notable Market Developments

  • In February 2016, Mesoblast Limited’s licensee in Japan, JCR Pharmaceuticals Co. Ltd., launched “TEMCELL HS Inj”, the first allogeneic cell therapy to be fully approved in Japan, for the treatment of acute graft versus host disease in children and adults

Key

Report Outline

Stem Cell Therapy Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.


Report

Table Of Content

  1. Executive summary
  2. Global Stem Cell Therapy Market Introduction
    • Global Stem Cell Therapy Market– Taxonomy
    • Global Stem Cell Therapy Market–Definitions
      • Treatment Type
      • Cell Type
  1. Global Stem Cell Therapy Market Dynamics
    • Drivers
    • Restraints
    • Opportunities/Unmet Needs of the Market
    • Trends
    • Global Stem Cell Therapy Market Dynamics – Factors Impact Analysis
    • Global Stem Cell Therapy Market– Regulations
      • US
      • Europe
      • Japan
  1. Global Stem Cell Therapy Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
    • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Market Oppurtunity Analysis
  2. Global Stem Cell Therapy Market, By Treatment Type, 2013 – 2017 and Forecast, 2018 – 2024
    • Allogeneic
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Autologous
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Stem Cell Therapy Market Forecast, By Cell Type, 2013 – 2017 and Forecast, 2018 – 2024
    • Adult Stem Cells
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Induced Pluripotent Stem Cells
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Human Embryonic Stem Cells
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Stem Cell Therapy Market Forecast, By End User, 2013 – 2017 and Forecast, 2018 – 2024
    • Hospitals
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Ambulatory Surgical Centers
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Research Centers
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Stem Cell Therapy Market Forecast, By Region, 2013 – 2017 and Forecast, 2018 – 2024
    • North America
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Europe
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Asia-Pacific
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Latin America
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Middle East and Africa
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Global Stem Cell Therapy Market- Opportunity Analysis Index – By Treatment Type, By Cell Type, By End User, and Region, 2018 – 2024
  2. North America Stem Cell Therapy Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
    • Treatment Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Allogeneic
      • Autologous
    • Cell Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Adult Stem Cells
      • Induced Pluripotent Stem Cells
      • Human Embryonic Stem Cells
      • Others
    • Technology Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Cell Production
      • Cell Acquisition
      • Cryopreservation
    • End User Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Ambulatory Surgical Centers
      • Research Centers
    • Country Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • US
      • Canada
    • North America Stem Cell Therapy Market- Opportunity Analysis Index – By Treatment Type, By Cell Type, By Technology, By End User, and Country, 2018 – 2024
    • North America Stem Cell Therapy Market Dynamics – Trends
  3. Europe Stem Cell Therapy Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
    • Treatment Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Allogeneic
      • Autologous
    • Cell Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Adult Stem Cells
      • Induced Pluripotent Stem Cells
      • Human Embryonic Stem Cells
      • Others
    • Technology Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Cell Production
      • Cell Acquisition
      • Cryopreservation
    • End User Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Ambulatory Surgical Centers
      • Research Centers
    • Country Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Germany
      • UK
      • France
      • Spain
      • Italy
      • Russia
      • Poland
      • Rest of Europe
    • Europe Stem Cell Therapy Market- Opportunity Analysis Index – By Treatement Type, By Cell Type Type, By Technology, By End User, and Country, 2018 – 2024
    • Europe Stem Cell Therapy Market Dynamics – Trends
  4. Asia-Pacific Stem Cell Therapy Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
    • Treatment Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Allogeneic
      • Autologous
    • Cell Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Adult Stem Cells
      • Induced Pluripotent Stem Cells
      • Human Embryonic Stem Cells
      • Others
    • Technology Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Cell Production
      • Cell Acquisition
      • Cryopreservation
    • End User Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Ambulatory Surgical Centers
      • Research Centers
    • Country Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn),
  5. Y-o-Y Growth (%), and Market Share (%)
    • Japan
    • China
    • India
    • ASEAN
    • Australia & New Zealand
    • Rest of Asia-Pacific
  • Asia-Pacific Stem Cell Therapy Market- Opportunity Analysis Index – By Treatement Type, By Cell Type Type, By Technology, By End User, and Country, 2018 – 2024
  • Asia-Pacific Stem Cell Therapy Market Dynamics – Trends
  1. Latin America Stem Cell Therapy Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
    • Treatment Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Allogeneic
      • Autologous
    • Cell Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Adult Stem Cells
      • Induced Pluripotent Stem Cells
      • Human Embryonic Stem Cells
      • Others
    • Technology Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Cell Production
      • Cell Acquisition
      • Cryopreservation
    • End User Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Ambulatory Surgical Centers
      • Research Centers
    • Country Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Brazil
      • Mexico
      • Argentina
      • Venezuela
      • Rest of Latin America
    • Latin America Stem Cell Therapy Market- Opportunity Analysis Index – By Treatement Type, By Cell Type Type, By Technology, By End User, and Country, 2018 – 2024
    • Latin America Stem Cell Therapy Market Dynamics – Trends
  2. Middle East & Africa Stem Cell Therapy Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
    • Treatment Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Allogeneic
      • Autologous
    • Cell Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Adult Stem Cells
      • Induced Pluripotent Stem Cells
      • Human Embryonic Stem Cells
      • Others
    • Technology Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Cell Production
      • Cell Acquisition
      • Cryopreservation
    • End User Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Ambulatory Surgical Centers
      • Research Centers
    • Country Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Gulf Cooperation Council (GCC) Countries
      • Israel
      • South Africa
      • Rest of MEA
    • MEA Stem Cell Therapy Market- Opportunity Analysis Index – By Treatment Type, By Cell Type, By Technology, By End User, and Country, 2018 – 2024
    • MEA Stem Cell Therapy Market Dynamics – Trends
  3. Competition Landscape
    • Strategic Dashboard of Top Market Players
    • Company Profiles (Introduction, Financial Analysis, Drug & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
      • Cytori Therapeutics Inc. (U.S.)
      • Fibrocell Science (U.S.)
      • Cellartis AB (Cellectis) (France)
      • BioTime, Inc. (U.S.)
      • GE Healthcare (U.S.)
      • Thermo Fisher Scientific (U.S.)
      • STEMCELL Technologies Inc. (Canada)
      • Fujifilm Holdings Corporation (Japan)
      • Vericel Corporation (Aastrom Bioscience) (U.S.)
      • Brainstorm cell therapeutics (U.S.)
      • Osiris Therapeutics, Inc. (U.S.)
  1. Research Methodology
  2. Key Assumptions and Acronyms

Report

Company Profile

  • Cytori Therapeutics Inc. (U.S.)
  • Fibrocell Science (U.S.)
  • Cellartis AB (Cellectis) (France)
  • BioTime, Inc. (U.S.)
  • GE Healthcare (U.S.)
  • Thermo Fisher Scientific (U.S.)
  • STEMCELL Technologies Inc. (Canada)
  • Fujifilm Holdings Corporation (Japan)
  • Vericel Corporation (Aastrom Bioscience) (U.S.)
  • Brainstorm cell therapeutics (U.S.)
  • Becton, Dickinson and Company (U.S.)
  • Stryker Corporation (U.S.)
  • Celgene Corporation (U.S.)
  • Osiris Therapeutics, Inc. (U.S.)

Description

Stem Cell Therapy Market size was valued at USD 16.5 billion in 2021 and is expected to reach USD 32.2 billion by 2028, at a CAGR of 10% during the forecast period 2022 to 2028. Stem cell therapy involves use of stem cells to treat various diseases or disorders. Stem cells are fundamental for every tissue and organ in the body.  Stem cells are indistinguishable biological cells that are able to differentiate into specialised cells (liver cells, cardiac cells etc.) and can renew itself (through mitosis) to produce more stem cells. Stem cells have the ability to replicate, repair, and replace other damaged tissues in the human body. In addition, stem cell based therapies are also used to treat several chronic diseases such as blood disorders, cancer and others. Stakeholders in stem cell therapy such as academic institutions and research firms are collaborating in development of stem cell therapy and industry collaborations also projecting enormous growth of stem cell therapy market. For instance, in November 2015, Cellular Dynamics International, Inc. (FUJIFILM) collaborated with Roche to supply iCell (CDI’s induced pluripotent stem cell derived) products that enables in identification of novel drug candidates at the early stages of drug discovery. Similarly, in May 2017, Magenta Therapeutics, entered into strategic partnership with Be The Match BioTherapies, to improve and expand the use of curative stem cell transplantation.

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX